BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 26150713)

  • 1. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of direct substitution of arm span length for current standing height in elderly COPD.
    Pothirat C; Chaiwong W; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1173-8. PubMed ID: 26150709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
    Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease.
    Emerman CL; Cydulka RK
    Ann Emerg Med; 1996 Feb; 27(2):159-63. PubMed ID: 8629745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV
    Li H; Liu C; Zhang Y; Xiao W
    Respir Care; 2017 Mar; 62(3):363-369. PubMed ID: 27999150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of clinical score and lung function tests in the classification of asthma by severity of disease].
    Nakaie CM; Rozov T; Manissadjian A
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(2):68-74. PubMed ID: 9699357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a claims-based prediction model for COPD severity.
    Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
    Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of heart failure on the classification of COPD severity.
    Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
    J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
    Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
    COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.